Patents by Inventor Peiying Yang

Peiying Yang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100189830
    Abstract: Sweet gum (Liquidambar styraciflua L., family Hamamelidaceae) fruit extract was discovered to possess potent activities against multiple targets of the PBK (phosphatidylinositide 3-kinase) pathway, especially the PI3K/Akt and mTOR pathways. At a very low concentration of 1.85 ?g/ml (IC50), sweet gun extract showed the ability of simultaneously blocking the pathways of PI3K/Akt (upstream), mTOR (mammalian target of rapamycin) (downstream), as well as its downstream protein products S6K and S6. It was also able to block 5-HETE, a lipoxygenase product that contributes to inflammation and activation of PI3K/Akt. The sweet gum fruit extract was prepared with 50% methanol (47:1; raw to extract) and concentrated to an organic fraction (210:1 raw to extract) referred as LIS-100 via reverse-phase column chromatography using a bioassay directed fractionation approach.
    Type: Application
    Filed: May 21, 2008
    Publication date: July 29, 2010
    Inventors: Zhijun Liu, Peiying Yang, Robert A. Newman
  • Patent number: 7744931
    Abstract: The inventive subject matter relates to methods for treating oral cancers, comprising administration of a composition comprising therapeutically effective amounts of supercritical extracts of rosemary, turmeric, oregano and ginger; and therapeutically effective amounts of hydroalcoholic extracts of holy basil, ginger, turmeric, Scutellaria baicalensis, rosemary, green tea, huzhang, Chinese goldthread, and barberry. The inventive subject matter further relates to methods for modulating gene expression of genes selected from the group consisting of interleukin-1?, interleukin-1?, heme oxygenase 1, aldo-keto reductase family 1, member C2, colony stimulating factor 3, leukemia inhibitory factor, heat shock 70 kDa protein, and combinations thereof, by administration of an effective amount of said compositions.
    Type: Grant
    Filed: November 8, 2007
    Date of Patent: June 29, 2010
    Assignees: New Chapter Inc., Board of Regents of the University of Texas System
    Inventors: Thomas Newmark, Robert Newman, Peiying Yang, Paul Schulick
  • Publication number: 20080233218
    Abstract: The inventive subject matter relates to methods for treating oral cancers, comprising administration of a composition comprising therapeutically effective amounts of supercritical extracts of rosemary, turmeric, oregano and ginger; and therapeutically effective amounts of hydroalcoholic extracts of holy basil, ginger, turmeric, Scutellaria baicalensis, rosemary, green tea, huzhang, Chinese goldthread, and barberry. The inventive subject matter further relates to methods for modulating gene expression of genes selected from the group consisting of interleukin-1?, interleukin-1?, heme oxygenase 1, aldo-keto reductase family 1, member C2, colony stimulating factor 3, leukemia inhibitory factor, heat shock 70 kDa protein, and combinations thereof, by administration of an effective amount of said compositions.
    Type: Application
    Filed: November 8, 2007
    Publication date: September 25, 2008
    Inventors: Thomas Newmark, Robert Newman, Peiying Yang, Paul Schulick
  • Patent number: 6541519
    Abstract: Methods and compositions are disclosed for prevention and/or treatment of diseases in which 5- and 12-lipoxygenase activity contributes to the pathological condition, by administration of 12-methyletradecanoic acids alone and in conjunction with other therapeutic compounds. Methods to inhibit lipoxygenase-mediated inflammations are disclosed.
    Type: Grant
    Filed: April 6, 2001
    Date of Patent: April 1, 2003
    Assignee: Coastside Bio Resources
    Inventors: Peter D. Collin, Peiying Yang, Robert Newman
  • Publication number: 20020013368
    Abstract: A method is disclosed for prevention and/or treatment of diseases in which 5- and 12-lipoxygenase activity contributes to the pathological condition, by administration of 12-methyltetradecanoic acids alone and in conjunction with other therapeutic compounds. Methods to inhibit lipoxygenase mediated cancers and inflammations are disclosed.
    Type: Application
    Filed: April 6, 2001
    Publication date: January 31, 2002
    Inventors: Peter D. Collin, Peiying Yang, Robert Newman